Dr. Khadijah completed her PhD in Materials Physics and Chemistry in 2018 supported as a MEXT scholar. Her PhD dissertation focused on developing nanoparticles for induction of immunotolerance towards the therapy of inflammation and allergic disease. During her M.S. she increased the oral bioavailability of Famotidine using solid lipid nanoparticles. Since her graduation she worked as a Lecturer at the Universitas Gadjah Mada where she has mentored several undergraduate and graduate students as well as served as PI on severl research awards. She joined the NanoBio Lab in February 2024 and focuses on developing biodegradable drug delivery solutions for breast and ovarian cancer.